MedPath

Immunity in Perioperative Practice

Recruiting
Conditions
cardia and esophagus cancer)
upper gastrointestinal cancer (stomach
10027656
Registration Number
NL-OMON53931
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
98
Inclusion Criteria

The participant is...
- Assigned to curative treatment for oesophageal cancer, cardia cancer or
stomach cancer, including chemoradiotherapy (CROSS) or chemotherapy (FLOT) and
surgical resection
- Above 18 years of age
- Able to understand and speak Dutch or English language

Exclusion Criteria

no exclusion criteria

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- neutrophil subtypes (assessed via immune markers: CD16, CD11b, CD62L, CD10,<br /><br>CD64, CD11b, CD169, CD14, HLA-DR)<br /><br>- complications<br /><br>- physical activity<br /><br>- physical fitness (aerobic capacity, handgrip strength, physical functioning)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- total leukocytes and neutrophils count<br /><br>- risk for malnutrition<br /><br>- nutritional intake<br /><br>- sleep<br /><br>- perceived immune fitness</p><br>
© Copyright 2025. All Rights Reserved by MedPath